Survodutide 10 mg
Main Image
Gallery Image

Survodutide 10 mg

Steroids Dragon Pharma Europe Peptides

$102.00

Trusted Dragon Pharma Survodutide Source

DragonPharma.Net offers genuine peptides from Dragon Pharma. Each 2 mL vial of Survodutide delivers a clinical-grade 10 mg dose of this advanced GLP-1 and glucagon receptor dual agonist.

What is Survodutide?

Survodutide is a next-generation peptide therapeutic engineered by Dragon Pharma to support fat loss, appetite regulation, and metabolic health. As a dual agonist of the GLP-1 and glucagon receptors, it enhances energy expenditure while reducing hunger signals, making it highly effective for individuals managing obesity, metabolic syndrome, or insulin resistance.

Learn more about Survodutide's mechanism of action and its clinical development path.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:
Brand: Dragon Pharma, Europe
Manufacturer: Dragon Pharma, Europe
Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage &amp; Usage Guidelines</h2> <p>Administered via weekly subcutaneous injections, Survodutide is typically started at a low dose and titrated upwards over several weeks. This approach minimizes gastrointestinal discomfort while achieving optimal metabolic outcomes. Typical protocols escalate from 0.6 mg/week up to 4.8 mg/week across a 16–20 week ramp-up phase, followed by a maintenance cycle.</p> <p>Dosage schedules should be individualized and supervised by a medical professional, especially for patients with comorbidities.</p> <h3>Example Survodutide Cycle</h3> <p>A standard example cycle begins with:</p> <ul> <li>Weeks 1–4: 0.6 mg/week</li> <li>Weeks 5–8: 1.2–2.4 mg/week</li> <li>Weeks 9–12: 3.0–3.6 mg/week</li> <li>Weeks 13–16: 4.8 mg/week (max dose)</li> <li>Weeks 17–24: Maintain at 4.8 mg/week</li> </ul> <p>Clinical benefits are most notable when Survodutide is paired with a caloric deficit and light physical activity.</p> <h3>Possible Adverse Effects</h3> <p>Survodutide is well tolerated by most users. Initial side effects can include <a href="https://medlineplus.gov/fatigue.html" rel="noopener" target="_blank">fatigue</a>, mild <a href="https://www.mayoclinic.org/diseases-conditions/dizziness/symptoms-causes/syc-20371787" rel="noopener" target="_blank">dizziness</a>, and gastrointestinal symptoms such as nausea or bloating. These effects usually subside as the body adapts.</p> <p>More serious side effects are rare but may include kidney strain or cardiovascular impacts in predisposed individuals. Periodic lab monitoring is advised, especially during prolonged use cycles.</p> <h3>Is Survodutide Right for You?</h3> <p>Survodutide may be a strong addition to any advanced fat-loss protocol. It's ideal for users looking to amplify body recomposition or support weight control where traditional strategies fall short.</p> <p>Survodutide is available in our <a href="https://www.dragonpharma.net/peptides-414">GLP-1 agonists category</a>, alongside other peptides designed to enhance fat metabolism and appetite regulation.</p> <h3>Why Choose Dragon Pharma Survodutide?</h3> <p>Dragon Pharma is known for delivering research-backed peptides with high purity and consistent dosing. Whether you're an athlete cutting for a show or managing long-term weight loss, this is one of the most potent metabolic enhancers on the market.</p> <p>Browse more <a href="/">Dragon Pharma gear</a> trusted by athletes and biohackers worldwide.</p> </section> </div>
Reviews:
(0 customer reviews)

Technical Details

Peptide Type
Lipidated Synthetic Peptide
Peptide Profile
Glucagon-Derived Peptide Analogue
Structural Profile
Long-Acting Acylated Peptide
Molecular Formula
C₁₉₂H₂₈₉N₄₇O₆₁
Molecular Weight
4232 g/mol
CAS Number
2805997-46-8
PubChem CID
168429725
Receptor Targets
GCGR + GLP-1R
Pharmacologic Profile
Dual Glucagon / GLP-1 Receptor Agonist
Development Code
BI 456906
Development Status
Investigational

Chat on WhatsApp